tiprankstipranks
Evoke Pharma (EVOK)
NASDAQ:EVOK
Holding EVOK?
Track your performance easily

Evoke Pharma (EVOK) Technical Analysis

464 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Evoke Pharma’s (EVOK) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Evoke Pharma is a Sell.
Evoke Pharma’s (EVOK) 20-Day exponential moving average is 4.62, while Evoke Pharma’s (EVOK) share price is $5.07, making it a Buy.
Evoke Pharma’s (EVOK) 50-Day exponential moving average is 4.78, while Evoke Pharma’s (EVOK) share price is $5.07, making it a Buy.

Evoke Pharma (EVOK) Pivot Points

Dec 22, 2024, 09:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.34
3.88
4.68
5.22
6.02
6.56
7.36
Fibonacci
3.88
4.39
4.70
5.22
5.73
6.04
6.56
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Evoke Pharma (EVOK) Moving Averages

Dec 22, 2024, 09:19 PM
Period
Simple
Exponential
MA5
4.83Buy
4.89Buy
MA10
4.56Buy
4.70Buy
MA20
4.44Buy
4.62Buy
MA50
4.97Buy
4.78Buy
MA100
4.90Buy
5.10Sell
MA200
5.59Sell
5.96Sell
Evoke Pharma’s (EVOK) 10-Day exponential moving average is 4.70, while Evoke Pharma’s (EVOK) share price is $5.07, making it a Buy.
Evoke Pharma’s (EVOK) 100-Day exponential moving average is 5.10, while Evoke Pharma’s (EVOK) share price is $5.07, making it a Sell.
Evoke Pharma’s (EVOK) stock price is $5.07 and Evoke Pharma’s (EVOK) 50-day simple moving average is 4.97, creating a Buy signal.
Evoke Pharma’s (EVOK) stock price is $5.07 and Evoke Pharma’s (EVOK) 100-day simple moving average is 4.90, creating a Buy signal.
Evoke Pharma’s (EVOK) stock price is $5.07 and Evoke Pharma’s (EVOK) 200-day simple moving average is 5.59, creating a Sell signal.

Evoke Pharma (EVOK) Technical Indicators

Dec 22, 2024, 09:19 PM
Name
Value
Implied Action
RSI (14)
56.75
Neutral
STOCH (9,6)
65.44
Neutral
STOCHRSI (14)
65.44
Neutral
MACD (12,26)
0.01
Sell
ADX (14)
20.93
Neutral
Williams %R
-39.31
Buy
CCI (14)
225.97
Sell
ATR (14)
0.45
-
Ultimate Oscillator
58.04
Neutral
ROC
16.55
Buy
Evoke Pharma’s (EVOK) Relative Strength Index (RSI) is 56.75, creating a Neutral signal.
Evoke Pharma’s (EVOK) Trend Strength Indicator (ADX) is 20.93, creating a Neutral signal.
Evoke Pharma’s (EVOK) Commodity Channel Index (CCI) is 225.97, creating a Sell signal.
Evoke Pharma’s (EVOK) Price Rate of Change (ROC) is 16.55, creating a Buy signal.

FAQ

Is EVOK a Buy, Hold, or Sell?
Based on EVOK’s technical indicators, EVOK is a Buy.
    What is EVOK’s RSI (14)?
    EVOK’s RSI (14) is 56.75, which suggests EVOK is a Neutral.
      What is EVOK’s MACD?
      EVOK’s MACD is 0.01, which suggests EVOK is a Sell.
        What is EVOK’s 5-day moving average?
        EVOK’s 5-day moving average is 4.83, which suggests EVOK is a Buy.
          What is EVOK’s 20-day moving average?
          EVOK 20-day moving average is 4.44, which suggests EVOK is a Buy.
            What is EVOK’s 50-day moving average?
            EVOK’s 50-day moving average is 4.97, which suggests EVOK is a Buy.
              What is EVOK’s 200-day moving average?
              EVOK’s 200-day moving average is 5.59, which suggests EVOK is a Sell.
                What is EVOK’s Williams % R (14)?
                EVOK’s Williams % R (14) is -39.31, which suggests EVOK is a Buy.
                  What is EVOK’s CCI (14)?
                  EVOK’s CCI (14) is 225.97, which suggests EVOK is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis